medigraphic.com
Revista Médica Sinergia

2017, Número 05

<< Anterior Siguiente >>

Revista Médica Sinergia 2017; 2 (05)


Embolismo pulmonar

Vindas GS

Idioma: Español
Referencias bibliográficas: 15
Paginas: 8-14
Archivo PDF: 221.12 Kb.


RESUMEN

El trombo generalmente se origina de los miembros inferiores en un 90-95% de los casos. Rara vez se origina en las venas de la pelvis, en las renales o extremidades superiores o en las cámaras del corazón derecho. Forma parte junto con la trombosis venosa profunda de la enfermedad tromboembólica venosa. El embolismo pulmonar (EP) es una condición que se asocia a una alta mortalidad y morbilidad. Se estima que más de 100.000 casos de EP ocurren anualmente.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Törő et al. Evaluation of meteorological and epidemiological characteristics of fatal pulmonary embolism. Int J Biometeorol 2015; DOI 10.1007/s00484-015-1032-8.

  2. C.Y. Wang et al. Risk factors and clinical features of acute pulmonary embolism in children from the community. Thrombosis Research 2016; 138: 86–90.

  3. Ostovan MA, et al. Modification of Simplified Pulmonary Embolism Severity Index and its Prognostic Value in Patients with Acute Pulmonary Embolism. Heart, Lung and Circulation (2015), http://dx.doi.org/ 10.1016/j.hlc.2015.08.008.

  4. Prandoni P et al. Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope. N Engl J Med 2016; 375: 1524-31.

  5. Marc A. Passman. Vena Cava Interruption and Pulmonary Embolism. In Cronenwett JL and Johnston WK. Rutherford’s Vascular Surgery. 8th ed. Editorial Elsevier; 2014: chap153

  6. Castuera AI, Fernández JH, Martínez EL, Muñoz IR. Tromboembolismo pulmonar. Medicine. 2015;11:5245-53.

  7. Jaffer IH, Weitz JI. Antithrombotic Therapy. In Cronenwett JL and Johnston WK. Rutherford’s Vascular Surgery. 8th ed. Editorial Elsevier; 2014: chap 35.

  8. Angriman et al. Wells Score and Poor Outcomes Among Adult Patients With Subsegmental Pulmonary Embolism: A Cohort Study. Clinical and Applied Thrombosis/Hemostasis 2014; 1-7; DOI: 10.1177/1076029614559772.

  9. G. Gao, et al., Thrombolysis for acute intermediate-risk pulmonary embolism: A meta- analysis, Thromb Res (2015), http://dx.doi.org/10.1016/j.thromres.2015.09.012

  10. Nasrin et al. Pulmonary embolism as a complication of an electrophysiological study: a case report. Journal of Medical Case Reports 2016; 10:89.DOI10.1186/s13256-016-0872-0

  11. Menichetti et al. Use of rivaroxaban in an elderly patient with intermediate-low early mortality risk due to pulmonary embolism: a case report. Journal of Medical Case Reports (2015) 9:274 DOI 10.1186/s13256-015-0758-6.

  12. Meinel FG, Nance JW Jr., Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P, Goldhaber SZ, Bamberg F, Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-Analysis, The American Journal of Medicine (2015), doi: 10.1016/j.amjmed.2015.01.023.

  13. Rucco et al. Neural hypernetwork approach for pulmonary embolism diagnosis. BMC Res Notes (2015) 8:617 DOI 10.1186/s13104-015-1554-5.

  14. Ates et al. What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia?.Blood Coagulation and Fibrinolysis 2016, 27:252–258.

  15. Li et al. Risk factors associated with the occurrence of silent pulmonary embolism in patients with deep venous thrombosis of the lower limb. Phlebology 2014; 29: 442-446. Recepción: 05 Febrero de 2017




2020     |     www.medigraphic.com